{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:12:24Z","timestamp":1776795144182,"version":"3.51.2"},"reference-count":231,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Muscle wasting, i.e., cachexia, frequently occurs in cancer and associates with poor prognosis and increased morbidity and mortality. Anticancer treatments have also been shown to contribute to sustainment or exacerbation of cachexia, thus affecting quality of life and overall survival in cancer patients. Pre-clinical studies have shown that blocking activin receptor type 2 (ACVR2) or its ligands and their downstream signaling can preserve muscle mass in rodents bearing experimental cancers, as well as in chemotherapy-treated animals. In tumor-bearing mice, the prevention of skeletal and respiratory muscle wasting was also associated with improved survival. However, the definitive proof that improved survival directly results from muscle preservation following blockade of ACVR2 signaling is still lacking, especially considering that concurrent beneficial effects in organs other than skeletal muscle have also been described in the presence of cancer or following chemotherapy treatments paired with counteraction of ACVR2 signaling. Hence, here, we aim to provide an up-to-date literature review on the multifaceted anti-cachectic effects of ACVR2 blockade in preclinical models of cancer, as well as in combination with anticancer treatments.<\/jats:p>","DOI":"10.3390\/cells10030516","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T20:43:32Z","timestamp":1614545012000},"page":"516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-2124","authenticated-orcid":false,"given":"Juha J.","family":"Hulmi","sequence":"first","affiliation":[{"name":"Faculty of Sport and Health Sciences, NeuroMuscular Research Center, University of Jyv\u00e4skyl\u00e4, 40014 Jyv\u00e4skyl\u00e4, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuuli A.","family":"Nissinen","sequence":"additional","affiliation":[{"name":"Faculty of Sport and Health Sciences, NeuroMuscular Research Center, University of Jyv\u00e4skyl\u00e4, 40014 Jyv\u00e4skyl\u00e4, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-6027","authenticated-orcid":false,"given":"Fabio","family":"Penna","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3235-1871","authenticated-orcid":false,"given":"Andrea","family":"Bonetto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-012-0074-6","article-title":"Molecular and cellular mechanisms of skeletal muscle atrophy: An update","volume":"3","author":"Fanzani","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ajcn\/84.3.475","article-title":"The underappreciated role of muscle in health and disease","volume":"84","author":"Wolfe","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"c4467","DOI":"10.1136\/bmj.c4467","article-title":"Objectively measured physical capability levels and mortality: Systematic review and meta-analysis","volume":"341","author":"Cooper","year":"2010","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000441-193211000-00002","article-title":"The immediate causes of death in cancer","volume":"184","author":"Warren","year":"1932","journal-title":"Am. J. Med Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Aydogdu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13395-016-0098-2","article-title":"ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments","volume":"6","author":"Hatakeyama","year":"2016","journal-title":"Skelet. Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ijc.29930","article-title":"Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and beta-2 agonist","volume":"138","author":"Toledo","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jcsm.12310","article-title":"Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses","volume":"9","author":"Nissinen","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32695","DOI":"10.1038\/srep32695","article-title":"Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes","volume":"6","author":"Nissinen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jcsm.12265","article-title":"Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle","volume":"9","author":"Hulmi","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"O\u2019Connell, T.M., Pin, F., Couch, M.E., and Bonetto, A. (2019). Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia. Cancers, 11.","DOI":"10.3390\/cancers11091222"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43442","DOI":"10.18632\/oncotarget.9779","article-title":"Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs","volume":"7","author":"Barreto","year":"2016","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2020.27.3.151","article-title":"Myostatin Inhibitors: Panacea or Predicament for Musculoskeletal Disorders?","volume":"27","author":"Suh","year":"2020","journal-title":"J. Bone Metab."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Rybalka, E., Timpani, C.A., Debruin, D.A., Bagaric, R.M., Campelj, D.G., and Hayes, A. (2020). The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle. Cells, 9.","DOI":"10.20944\/preprints202010.0234.v1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/canjclin.57.4.225","article-title":"The lethal phenotype of cancer: The molecular basis of death due to malignancy","volume":"57","author":"Loberg","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_23","first-page":"e54893","article-title":"The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia","volume":"117","author":"Bonetto","year":"2016","journal-title":"J. Vis. Exp."},{"key":"ref_24","first-page":"533","article-title":"Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia","volume":"5","author":"Murphy","year":"2012","journal-title":"Dis. Models Mech."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"dmm043166","DOI":"10.1242\/dmm.043166","article-title":"HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia","volume":"13","author":"Huot","year":"2020","journal-title":"Dis. Models Mech."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jcsm.12311","article-title":"Growth of ovarian cancer xenografts causes loss of muscle and bone mass: A new model for the study of cancer cachexia","volume":"9","author":"Pin","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","article-title":"Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes","volume":"54","author":"Mazurak","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fphys.2019.00041","article-title":"The Skeletal Muscle as an Active Player against Cancer Cachexia","volume":"10","author":"Penna","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.1993.126","article-title":"Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia","volume":"67","author":"Smith","year":"1993","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1152\/ajpregu.2001.281.1.R133","article-title":"Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice","volume":"281","author":"Samuels","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"White, J.P., Baynes, J.W., Welle, S.L., Kostek, M.C., Matesic, L.E., Sato, S., and Carson, J.A. (2011). The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024650"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Horstman, A.M., Olde Damink, S.W., Schols, A.M., and van Loon, L.J. (2016). Is Cancer Cachexia Attributed to Impairments in Basal or Postprandial Muscle Protein Metabolism?. Nutrients, 8.","DOI":"10.3390\/nu8080499"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101046","DOI":"10.1016\/j.molmet.2020.101046","article-title":"Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia-the effects of blocking myostatin and activins","volume":"41","author":"Hulmi","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2015.09.009","article-title":"Impaired regeneration: A role for the muscle microenvironment in cancer cachexia","volume":"54","author":"Talbert","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_37","first-page":"2771","article-title":"Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis","volume":"62","author":"Tilignac","year":"2002","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0026-0495(95)90040-3","article-title":"Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats","volume":"44","author":"Gugins","year":"1995","journal-title":"Metabolism"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","article-title":"Mediators of cachexia in cancer patients","volume":"66","author":"Argiles","year":"2019","journal-title":"Nutrition"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: Challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1089\/ars.2011.3965","article-title":"Chemotherapy-induced weakness and fatigue in skeletal muscle: The role of oxidative stress","volume":"15","author":"Gilliam","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"13144","DOI":"10.1073\/pnas.1616168113","article-title":"VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection","volume":"113","author":"Rasanen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s13105-012-0200-0","article-title":"Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function","volume":"69","author":"Hayward","year":"2013","journal-title":"J. Physiol. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Braun, T.P., Szumowski, M., Levasseur, P.R., Grossberg, A.J., Zhu, X., Agarwal, A., and Marks, D.L. (2014). Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106489"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000241723","article-title":"Differential contractile impairment of fast- and slow-twitch skeletal muscles in a rat model of doxorubicin-induced congestive heart failure","volume":"84","author":"Ertunc","year":"2009","journal-title":"Pharmacology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1152\/japplphysiol.00776.2009","article-title":"Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle","volume":"107","author":"Gilliam","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mus.21809","article-title":"Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy","volume":"43","author":"Gilliam","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"L225","DOI":"10.1152\/ajplung.00264.2010","article-title":"TNF\/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness","volume":"300","author":"Gilliam","year":"2011","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1038\/srep08717","article-title":"Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle","volume":"5","author":"Gouspillou","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_50","first-page":"2023","article-title":"Characterization of the effect of in vivo doxorubicin treatment on skeletal muscle function in the rat","volume":"31","author":"Hydock","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1113\/jphysiol.2014.286518","article-title":"Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy","volume":"593","author":"Min","year":"2015","journal-title":"J. Physiol."},{"key":"ref_52","first-page":"288","article-title":"Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity","volume":"118","author":"Doroshow","year":"1985","journal-title":"Am. J. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e13400","DOI":"10.1111\/apha.13400","article-title":"Doxorubicin-induced skeletal muscle atrophy: Elucidating the underlying molecular pathways","volume":"229","author":"Hiensch","year":"2019","journal-title":"Acta Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1152\/japplphysiol.00429.2011","article-title":"Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle","volume":"111","author":"Smuder","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1096\/fj.06-6604com","article-title":"Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases","volume":"21","author":"Sacheck","year":"2007","journal-title":"FASEB J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"14470-1","DOI":"10.1038\/s41598-017-15040-1","article-title":"ACVR2B\/Fc counteracts chemotherapy-induced loss of muscle and bone mass","volume":"7","author":"Barreto","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fphys.2016.00472","article-title":"Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways","volume":"7","author":"Barreto","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Huot, J.R., Essex, A.L., Gutierrez, M., Barreto, R., Wang, M., Waning, D.L., Plotkin, L.I., and Bonetto, A. (2019). Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac Muscles. Cancers, 11.","DOI":"10.3390\/cancers11040571"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/en.2007-0828","article-title":"Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia","volume":"149","author":"Garcia","year":"2008","journal-title":"Endocrinology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2617-1619.2019.tb00011.x","article-title":"Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia","volume":"2","author":"Hain","year":"2019","journal-title":"JCSM Rapid Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fendo.2019.00809","article-title":"Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice","volume":"10","author":"Essex","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer","volume":"66","author":"Barret","year":"2014","journal-title":"Nutr. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejso.2014.11.040","article-title":"Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer","volume":"41","author":"Tan","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1245\/s10434-014-4285-2","article-title":"Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer","volume":"22","author":"Cooper","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1139\/apnm-2013-0403","article-title":"The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer","volume":"39","author":"Prado","year":"2014","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/01635581.2013.828084","article-title":"Discrepancy between body surface area and body composition in cancer","volume":"65","author":"Stobaus","year":"2013","journal-title":"Nutr. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SPC.0000000000000382","article-title":"Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition","volume":"12","author":"Pin","year":"2018","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1535-7163.MCT-16-0337","article-title":"Dual Inhibition of MEK and PI3K\/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities","volume":"16","author":"Talbert","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"212265","DOI":"10.7573\/dic.212265","article-title":"One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA","volume":"3","author":"Arthur","year":"2014","journal-title":"Drugs Context"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1158\/1078-0432.CCR-07-1147","article-title":"Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia","volume":"13","author":"Fouladiun","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"27-4","DOI":"10.1186\/s12957-018-1327-4","article-title":"Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: A retrospective cohort study","volume":"16","author":"Jarvinen","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/1759-7714.12855","article-title":"Low skeletal muscle mass in stented esophageal cancer predicts poor survival: A retrospective observational study","volume":"9","author":"Jarvinen","year":"2018","journal-title":"Thorac. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpainsymman.2011.09.010","article-title":"Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: A pilot study","volume":"44","author":"Dalal","year":"2012","journal-title":"J. Pain Symptom Manag."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Stene","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13539-014-0145-y","article-title":"Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?","volume":"5","author":"Fogelman","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jcsm.12305","article-title":"The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: A population-based cohort study (C-SCANS)","volume":"9","author":"Brown","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejh.12285","article-title":"Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"93","author":"Camus","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br. J. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00535-014-0964-9","article-title":"Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma","volume":"50","author":"Iritani","year":"2015","journal-title":"J. Gastroenterol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MCG.0b013e318293a825","article-title":"Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma","volume":"47","author":"Baracos","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1245\/s10434-014-4281-6","article-title":"Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer","volume":"22","author":"Miyamoto","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11605-012-1923-5","article-title":"Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma","volume":"16","author":"Peng","year":"2012","journal-title":"J. Gastrointest. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.28798","article-title":"Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality","volume":"120","author":"Psutka","year":"2014","journal-title":"Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bjs.7823","article-title":"Body composition and outcome in patients undergoing resection of colorectal liver metastases","volume":"99","author":"Levolger","year":"2012","journal-title":"Br. J. Surg."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.ejca.2013.06.026","article-title":"Body composition and survival in the early clinical trials setting","volume":"49","author":"Baracos","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/SLA.0000000000000743","article-title":"Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma","volume":"261","author":"Voron","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jso.23862","article-title":"Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma","volume":"111","author":"Joglekar","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/hpb.12373","article-title":"Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?","volume":"17","author":"Lodewick","year":"2015","journal-title":"HPB"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1477-2574.2011.00301.x","article-title":"Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis","volume":"13","author":"Peng","year":"2011","journal-title":"HPB"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clnu.2015.08.005","article-title":"The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma","volume":"35","author":"Rollins","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jcsm.12642","article-title":"ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia","volume":"11","author":"Huot","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1096\/fj.12-222844","article-title":"Diaphragm and ventilatory dysfunction during cancer cachexia","volume":"27","author":"Roberts","year":"2013","journal-title":"FASEB J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.1993.03500060083036","article-title":"Intensive care, survival, and expense of treating critically ill cancer patients","volume":"269","author":"Schapira","year":"1993","journal-title":"JAMA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.md.0000145370.63676.fb","article-title":"The prognosis of acute respiratory failure in critically ill cancer patients","volume":"83","author":"Azoulay","year":"2004","journal-title":"Medicine"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1378\/chest.115.3.836","article-title":"Cardiac cachexia: A syndrome with impaired survival and immune and neuroendocrine activation","volume":"115","author":"Anker","year":"1999","journal-title":"Chest"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jcsm.12537","article-title":"MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia","volume":"11","author":"Potsch","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","article-title":"Myostatin gene inactivation prevents skeletal muscle wasting in cancer","volume":"74","author":"Gallot","year":"2014","journal-title":"Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"Pretto","year":"2015","journal-title":"Oncotarget"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","article-title":"Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia","volume":"107","author":"Tseng","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/molehr\/gam055","article-title":"Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein","volume":"13","author":"Li","year":"2007","journal-title":"Mol. Hum. Reprod."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-013-0111-0","article-title":"Why cachexia kills: Examining the causality of poor outcomes in wasting conditions","volume":"4","author":"Rhee","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","article-title":"Tgf-beta superfamily signaling in embryonic development and homeostasis","volume":"16","author":"Wu","year":"2009","journal-title":"Dev. Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ng0997-71","article-title":"A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle","volume":"17","author":"Grobet","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1101\/gr.7.9.910","article-title":"Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle","volume":"7","author":"Kambadur","year":"1997","journal-title":"Genome Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","article-title":"Double muscling in cattle due to mutations in the myostatin gene","volume":"94","author":"McPherron","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-291X(02)02953-4","article-title":"Inhibition of myostatin in adult mice increases skeletal muscle mass and strength","volume":"300","author":"Whittemore","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mrd.1097","article-title":"Expression of myostatin pro domain results in muscular transgenic mice","volume":"60","author":"Yang","year":"2001","journal-title":"Mol. Reprod. Dev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/en.2006-1500","article-title":"Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression","volume":"148","author":"Durieux","year":"2007","journal-title":"Endocrinology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/10320","article-title":"Regulation of anterior\/posterior patterning of the axial skeleton by growth\/differentiation factor","volume":"22","author":"McPherron","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"81604","DOI":"10.18632\/oncotarget.20258","article-title":"Role of growth differentiation factor 11 in development, physiology and disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"531","DOI":"10.15252\/emmm.201607231","article-title":"Supraphysiological levels of GDF11 induce striated muscle atrophy","volume":"9","author":"Hammers","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-213X-9-24","article-title":"Redundancy of myostatin and growth\/differentiation factor 11 function","volume":"9","author":"McPherron","year":"2009","journal-title":"BMC Dev. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/CIRCRESAHA.116.308391","article-title":"Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation","volume":"118","author":"Walker","year":"2016","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/physrev.00002.2018","article-title":"Activin A in Mammalian Physiology","volume":"99","author":"Bloise","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/321776a0","article-title":"Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid","volume":"321","author":"Vale","year":"1986","journal-title":"Nature"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"a021881","DOI":"10.1101\/cshperspect.a021881","article-title":"Activins and Inhibins: Roles in Development, Physiology, and Disease","volume":"8","author":"Namwanje","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","article-title":"Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice","volume":"91","author":"Matzuk","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"FASEB J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1152\/ajpendo.00193.2009","article-title":"Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin","volume":"297","author":"Gilson","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/me.2010-0127","article-title":"Regulation of muscle mass by follistatin and activins","volume":"24","author":"Lee","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"ref_134","first-page":"E5266","article-title":"Specific targeting of TGF-beta family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-319-27511-6_5","article-title":"The TGF-beta Signalling Network in Muscle Development, Adaptation and Disease","volume":"900","author":"Chen","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1182\/blood.V83.8.2163.2163","article-title":"Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor","volume":"83","author":"Hilden","year":"1994","journal-title":"Blood"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0092-8674(91)90549-E","article-title":"Expression cloning of an activin receptor, a predicted transmembrane serine kinase","volume":"65","author":"Mathews","year":"1991","journal-title":"Cell"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Lautaoja, J.H., Pekkala, S., Pasternack, A., Laitinen, M., Ritvos, O., and Hulmi, J.J. (2020). Differentiation of Murine C2C12 Myoblasts Strongly Reduces the Effects of Myostatin on Intracellular Signaling. Biomolecules, 10.","DOI":"10.3390\/biom10050695"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cellsig.2004.08.003","article-title":"Regulation of GDF-8 signaling by the p38 MAPK","volume":"17","author":"Philip","year":"2005","journal-title":"Cell. Signal."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-05-3060","article-title":"Extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MCO.0000000000000172","article-title":"Bone and morphogenetic protein signalling and muscle mass","volume":"18","author":"Sartori","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"13388","DOI":"10.18632\/oncotarget.7796","article-title":"High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma","volume":"7","author":"Hoda","year":"2016","journal-title":"Oncotarget"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating Activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/jcsm.12461","article-title":"The systemic activin response to pancreatic cancer: Implications for effective cancer cachexia therapy","volume":"10","author":"Zhong","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of Activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/j.cllc.2019.10.013","article-title":"Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy","volume":"21","author":"Paajanen","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"ref_149","unstructured":"Talar-Wojnarowska, R., Wozniak, M., Borkowska, A., Olakowski, M., and Malecka-Panas, E. (2020). Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss. J. Physiol. Pharmacol., 71."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/14728222.2020.1799350","article-title":"Activin A: An emerging target for improving cancer treatment?","volume":"24","author":"Ries","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Miyamoto, Y., Schirripa, M., Suenaga, M., Cao, S., Zhang, W., Okazaki, S., Berger, M.D., Matsusaka, S., Yang, D., and Ning, Y. (2020). A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239439"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1245\/s10434-011-1720-5","article-title":"Changes in myostatin signaling in non-weight-losing cancer patients","volume":"19","author":"Aversa","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.23798","article-title":"Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients","volume":"48","author":"Bonetto","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00415-016-8379-6","article-title":"Reduced serum myostatin concentrations associated with genetic muscle disease progression","volume":"264","author":"Burch","year":"2017","journal-title":"J. Neurol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/156652312800840577","article-title":"Interference with myostatin\/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy","volume":"12","author":"Amthor","year":"2012","journal-title":"Curr. Gene Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/mt.2014.221","article-title":"Development of novel activin-targeted therapeutics","volume":"23","author":"Chen","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41598-021-81669-8","article-title":"Novel myostatin-specific antibody enhances muscle strength in muscle disease models","volume":"11","author":"Muramatsu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1152\/ajpregu.00121.2011","article-title":"Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice","volume":"301","author":"Murphy","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e21387","DOI":"10.1096\/fj.202002008R","article-title":"Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fasting","volume":"35","author":"Nissinen","year":"2021","journal-title":"FASEB J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1152\/ajpendo.00389.2012","article-title":"Muscle protein synthesis, mTORC1\/MAPK\/Hippo signaling, and capillary density are altered by blocking of myostatin and activins","volume":"304","author":"Hulmi","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mus.23539","article-title":"A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers","volume":"47","author":"Attie","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study","volume":"65","author":"Rooks","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: Molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/mt.2014.90","article-title":"Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy","volume":"22","author":"Relizani","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2174\/156800909789057015","article-title":"Deacetylase inhibitors modulate the myostatin\/follistatin axis without improving cachexia in tumor-bearing mice","volume":"9","author":"Bonetto","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1210\/en.2019-00257","article-title":"Activin A-Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male Mice","volume":"160","author":"Walton","year":"2019","journal-title":"Endocrinology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0049-z","article-title":"Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance","volume":"3","author":"Busquets","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jcsm.12035","article-title":"A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy","volume":"7","author":"Toledo","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e2033457","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of Bimagrumab vs. Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Random-ized Clinical Trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcsm.12307","article-title":"Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer","volume":"9","author":"Kays","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40279-019-01107-8","article-title":"Exercise-Induced Myofibrillar Hypertrophy is a Contributory Cause of Gains in Muscle Strength","volume":"49","author":"Taber","year":"2019","journal-title":"Sports Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jcsm.12647","article-title":"Blocking myostatin: Muscle mass equals muscle strength?","volume":"11","author":"Anker","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e2020836","DOI":"10.1001\/jamanetworkopen.2020.20836","article-title":"Bimagrumab vs. Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial","volume":"3","author":"Rooks","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"9826-9","DOI":"10.1038\/s41598-019-46178-9","article-title":"Inhibition of activin-like kinase 4\/5 attenuates cancer cachexia associated muscle wasting","volume":"9","author":"Levolger","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mce.2014.10.001","article-title":"Myostatin\/activin blocking combined with exercise reconditions skeletal muscle expression profile of mdx mice","volume":"399","author":"Kainulainen","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2019.06.014","article-title":"New evidence of exercise training benefits in myostatin-deficient mice: Effect on lipidomic abnormalities","volume":"516","author":"Baati","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Chiappalupi, S., Sorci, G., Vukasinovic, A., Salvadori, L., Sagheddu, R., Coletti, D., Renga, G., Romani, L., Donato, R., and Riuzzi, F. (2020). Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia. J. Cachexia Sarcopenia Muscle.","DOI":"10.1002\/jcsm.12561"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.devcel.2018.05.026","article-title":"Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia","volume":"45","author":"Parajuli","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argiles","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/SPC.0b013e3283186be2","article-title":"Cachexia, survival and the acute phase response","volume":"2","author":"Stephens","year":"2008","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Bonetto, A., Aydogdu, T., Kunzevitzky, N., Guttridge, D.C., Khuri, S., Koniaris, L.G., and Zimmers, T.A. (2011). STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022538"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1152\/ajpheart.00720.2015","article-title":"The pathogenesis and treatment of cardiac atrophy in cancer cachexia","volume":"310","author":"Murphy","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fcimb.2019.00305","article-title":"Targeting the Gut Microbiota to Treat Cachexia","volume":"9","author":"Genton","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia","volume":"10","author":"Bindels","year":"2016","journal-title":"ISME J."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Herremans, K.M., Riner, A.N., Cameron, M.E., and Trevino, J.G. (2019). The Microbiota and Cancer Cachexia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246267"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fphys.2016.00679","article-title":"Differential Bone Loss in Mouse Models of Colon Cancer Cachexia","volume":"7","author":"Bonetto","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ymthe.2019.01.013","article-title":"Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury","volume":"27","author":"Magga","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1073\/pnas.2019263117","article-title":"Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A","volume":"117","author":"Lee","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","article-title":"Altered exocrine function can drive adipose wasting in early pancreatic cancer","volume":"558","author":"Danai","year":"2018","journal-title":"Nature"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/annonc\/mdx810","article-title":"Sarcopenic obesity: Hidden muscle wasting and its impact for survival and complications of cancer therapy","volume":"29","author":"Baracos","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1194\/jlr.M039719","article-title":"Follistatin promotes adipocyte differentiation, browning, and energy metabolism","volume":"55","author":"Braga","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00526.2018","article-title":"Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade","volume":"316","author":"Lautaoja","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e113931","DOI":"10.1371\/journal.pone.0113931","article-title":"Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: The role of STAT","volume":"9","author":"Toledo","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"43202","DOI":"10.18632\/oncotarget.6439","article-title":"Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations","volume":"6","author":"Pin","year":"2015","journal-title":"Oncotarget"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1194\/jlr.M038406","article-title":"Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models","volume":"54","author":"Penna","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41598-018-19572-y","article-title":"Preoperative anemia in colorectal cancer: Relationships with tumor characteristics, systemic inflammation, and survival","volume":"8","author":"Vayrynen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/jso.24940","article-title":"Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma","volume":"117","author":"Lewis","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cyto.1998.0398","article-title":"Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer","volume":"11","author":"Martin","year":"1999","journal-title":"Cytokine"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41416-018-0136-4","article-title":"High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer","volume":"119","author":"Sirnio","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Talbert, E.E., Lewis, H.L., Farren, M.R., Ramsey, M.L., Chakedis, J.M., Rajasekera, P., Haverick, E., Sarna, A., Bloomston, M., and Pawlik, T.M. (2018). Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naive pancreatic cancer patients. J. Cachexia Sarcopenia Muscle.","DOI":"10.1002\/jcsm.12251"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2005.07.026","article-title":"Liver protein synthesis stays elevated after chemotherapy in tumour-bearing mice","volume":"239","author":"Samuels","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/ajpendo.2000.279.3.E707","article-title":"Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients","volume":"279","author":"Barber","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jid.2017.07.845","article-title":"Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion","volume":"137","author":"Donovan","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"102314","DOI":"10.1016\/j.jaut.2019.102314","article-title":"Activin-A in the regulation of immunity in health and disease","volume":"104","author":"Morianos","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.4049\/jimmunol.1302895","article-title":"Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexia","volume":"192","author":"Cuenca","year":"2014","journal-title":"J. Immunol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/0008-5472.CAN-10-2670","article-title":"Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice","volume":"71","author":"Lesinski","year":"2011","journal-title":"Cancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/blood-2013-06-511238","article-title":"Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine beta-thalassemia","volume":"123","author":"Suragani","year":"2014","journal-title":"Blood"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4158\/EP12141.RA","article-title":"Bone as an endocrine organ","volume":"18","author":"Guntur","year":"2012","journal-title":"Endocr. Pract."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bone.2015.04.014","article-title":"Bone and skeletal muscle: Key players in mechanotransduction and potential overlapping mechanisms","volume":"80","author":"Goodman","year":"2015","journal-title":"Bone"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bone.2015.02.010","article-title":"Bone and muscle: Interactions beyond mechanical","volume":"80","author":"Brotto","year":"2015","journal-title":"Bone"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Puolakkainen, T., Rummukainen, P., Lehto, J., Ritvos, O., Hiltunen, A., Saamanen, A.M., and Kiviranta, R. (2017). Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180593"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat. Med."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Huot, J.R., Novinger, L.J., Pin, F., Narasimhan, A., Zimmers, T.A., O\u2019Connell, T.M., and Bonetto, A. (2020). Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities consistent with exacerbated cachexia. JCI Insight, 5.","DOI":"10.1172\/jci.insight.136687"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.18632\/oncotarget.14139","article-title":"Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo","volume":"8","author":"Wright","year":"2017","journal-title":"Oncotarget"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2013.12.002","article-title":"A myostatin and activin decoy receptor enhances bone formation in mice","volume":"60","author":"Bialek","year":"2014","journal-title":"Bone"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00395-017-0639-9","article-title":"Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting","volume":"112","author":"Zimmers","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","article-title":"Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells","volume":"109","author":"David","year":"2007","journal-title":"Blood"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mus.25268","article-title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Vaughan, D., Mitchell, R., Kretz, O., Chambers, D., Lalowski, M., Amthor, H., Ritvos, O., Pasternack, A., Matsakas, A., and Vaiyapuri, S. (2021). A muscle growth promoting treatment based on the attenuation of activin\/myostatin signalling in young mice results in long-term testicular abnormalities. Dis. Models Mech.","DOI":"10.1242\/dmm.047555"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"115036","DOI":"10.1016\/j.bone.2019.115036","article-title":"Novel ActRIIB ligand trap increases muscle mass and improves bone geometry in a mouse model of severe osteogenesis imperfecta","volume":"128","author":"Tauer","year":"2019","journal-title":"Bone"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Pekkala, S., Keskitalo, A., Kettunen, E., Lensu, S., Nykanen, N., Kuopio, T., Ritvos, O., Hentila, J., Nissinen, T.A., and Hulmi, J.J. (2019). Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota-A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?. Cancers, 11.","DOI":"10.3390\/cancers11111799"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00016489.2016.1277263","article-title":"Cachexia at diagnosis is associated with poor survival in head and neck cancer patients","volume":"137","author":"Osterlund","year":"2017","journal-title":"Acta Otolaryngol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1152\/japplphysiol.00685.2018","article-title":"Stimuli and sensors that initiate skeletal muscle hypertrophy following resistance exercise","volume":"126","author":"Wackerhage","year":"2019","journal-title":"J. Appl. Physiol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s40279-017-0673-7","article-title":"A Scientific Rationale to Improve Resistance Training Prescription in Exercise Oncology","volume":"47","author":"Fairman","year":"2017","journal-title":"Sports Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1096\/fj.201903055R","article-title":"A novel voluntary weightlifting model in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway","volume":"34","author":"Cui","year":"2020","journal-title":"FASEB J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1152\/japplphysiol.00319.2020","article-title":"Making Mice Mighty: Recent advances in translational models of load-induced muscle hypertrophy","volume":"129","author":"Murach","year":"2020","journal-title":"J. Appl. Physiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1096\/fj.201801862R","article-title":"Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations","volume":"33","author":"Ballaro","year":"2019","journal-title":"FASEB J."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Aquila, G., Re Cecconi, A.D., Brault, J.J., Corli, O., and Piccirillo, R. (2020). Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia. Cells, 9.","DOI":"10.3390\/cells9122536"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/3\/516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:30:34Z","timestamp":1760160634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/3\/516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":231,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["cells10030516"],"URL":"https:\/\/doi.org\/10.3390\/cells10030516","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,28]]}}}